Segments - Blood Pressure Monitoring Devices Market by Product (Ambulatory Blood Pressure Monitors, Transducers, Instruments & Accessories, Sphygmomanometer/Aneroid BP Monitors, Automated/Digital Blood Pressure Monitors, and Others), End-user (Homecare, Hospitals & Clinics, and Ambulatory Surgical Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global blood pressure monitoring devices market size was USD 4.6 Billion in 2023 and is projected to reach USD 10.33 Billion by 2032, expanding at a CAGR of 9.5% during 2024–2032. The market growth is attributed to the growing demand for proactive health management solutions.
Rising geriatric population afflicted with cardiovascular disorders is boosting the demand for patient monitoring devices, including blood pressure monitoring devices. For instance, according to the report published by the WHO, the global population aged 60 years and above reached 1.4 billion in 2020. Furthermore, the global population of people aged 60 years and above is expected to reach 2.1 billion by 2050.
Blood pressure monitoring devices provide real-time monitoring of blood pressure levels, facilitating early detection of abnormalities and delivering personalized insights to patients. Additionally, collaborations between medical device manufacturers and research institutes aimed at advancing blood pressure monitoring devices further fuel the market.
The use of artificial intelligence is likely to boost the blood pressure monitoring devices market. AI-powered blood pressure monitors use advanced signal-processing techniques to detect subtle changes in blood pressure patterns. Additionally, AI-enabled telemedicine platforms leverage machine learning algorithms to remotely monitor patients' blood pressure levels and provide timely interventions.
Increasing prevalence of hypertension and cardiovascular diseases worldwide is expected to drive the market in the coming years. Unhealthy lifestyles, sedentary habits, and poor dietary choices are contributing to the increased incidence of hypertension and heart related diseases. For instance, as per the report published by the WHO on June 11, 2021, around 17.9 million people died from cardiovascular diseases (CVDs) in 2019, accounting for 32% of total global fatalities. 85% of these deaths were caused by heart attacks and strokes. Furthermore, the surging demand for advanced blood pressure monitors is projected to fuel the market during the forecast period.
Stringent regulatory requirements and prolonged approval processes for blood pressure monitoring devices hinder the market. Regulatory approvals from organizations, such as the US FDA and the European Medicines Agency (EMA), are essential for the commercialization of these devices. Moreover, the limited reimbursement policies for blood pressure monitoring devices in certain regions hamper the market.
Growing adoption of telemedicine and remote patient monitoring solutions creates immense opportunities for the players competing in the market. Manufacturers are producing advanced blood pressure monitoring devices equipped with wireless connectivity and smartphone integration to enable patients to monitor their blood pressure levels remotely. Additionally, the rising demand for cutting-edge healthcare devices for monitoring daily health status is anticipated to boost the adoption of blood pressure monitoring devices in the coming years.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes |
Details |
Report Title |
Blood Pressure Monitoring Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017 -2022 |
Forecast Period |
2024–2032 |
Segmentation |
Product (Ambulatory Blood Pressure Monitors, Transducers, Instruments & Accessories, Sphygmomanometer/Aneroid BP Monitors, Automated/Digital Blood Pressure Monitors, and Others) and End-user (Homecare, Hospitals & Clinics, and Ambulatory Surgical Centers) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Biotronik; FUKUDA DENSHI; General Electric Company; Hill-rom Services, Inc; iRhythm Technologies Inc; Koninklijke Philips N.V; Nihon Kohden Corporation; Shenzhen Mindray Bio-Medical Electronics Co., Ltd; and ZOLL Medical Corporation |
In terms of region, the global blood pressure monitoring devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to advanced healthcare infrastructure and high adoption of innovative medical technologies, including advanced blood pressure monitoring devices, in the region. Moreover, the growing incidence of cardiovascular diseases in this region boosts the demand for blood pressure monitoring devices, aiding in the efficient management and prevention of cardiac conditions.
According to the Centers for Disease Control and Prevention's report published on May 15, 2023, cardiovascular disease results in one death in every 33 seconds in the US. In 2021, approximately 695,000 individuals in the US were affected by heart disease.
The market in Asia Pacific is projected to grow at a significant pace in the years to come, owing to the high prevalence of hypertension and cardiovascular diseases. Moreover, the government initiatives aimed at improving healthcare infrastructure and expanding access to medical services are expected to boost the demand for blood pressure monitoring devices.
Based on product, the blood pressure monitoring devices market is divided into ambulatory blood pressure monitors, transducers, instruments & accessories, sphygmomanometer/aneroid BP monitors, automated/digital blood pressure monitors, and others. The automated/digital blood pressure monitors segment held a large share of the market in 2023, due to their convenience, accuracy, and ease of use. Additionally, advancements in medical device technology, such as oscillometric measurement methods and digital displays, enhance the performance and usability of automated blood pressure monitors, thereby propelling the segment.
The ambulatory blood pressure monitors segment is expected to expand at a significant growth rate in the coming years, owing to the growing need for continuous blood pressure monitoring outside clinical settings. Ambulatory blood pressure monitors are portable devices worn by patients for 24 hours or longer to track their blood pressure throughout the day. Moreover, the increasing focus on preventive healthcare and early detection of cardiovascular diseases is expected to boost the demand for ambulatory blood pressure monitoring devices.
On the basis of end-user, the global market is segregated into homecare, hospitals & clinics, and ambulatory surgical centers. The homecare segment is anticipated to expand at a substantial CAGR during the forecast period, due to the rising preference for home-based healthcare solutions. Blood pressure monitoring devices allow patients to monitor their blood pressure levels regularly in the comfort of their homes, thereby reducing unnecessary visits to hospitals. Additionally, the COVID-19 pandemic has accelerated the shift toward home-based healthcare services, which boosts the demand for blood pressure monitoring devices for home use.
The blood pressure monitoring devices market has been segmented on the basis of
Key players competing in the global blood pressure monitoring devices market are Biotronik; FUKUDA DENSHI; General Electric Company; Hill-rom Services, Inc; iRhythm Technologies Inc; Koninklijke Philips N.V; Nihon Kohden Corporation; Shenzhen Mindray Bio-Medical Electronics Co., Ltd; and ZOLL Medical Corporation.
These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide. For instance,
On January 26, 2022, Koninklijke Philips N.V, a medical devices and solutions manufacturer, unveiled a 12-lead, at-home electrocardiogram (ECG) solution. This clinical-grade innovation marks a substantial leap forward in patient-centric ECG offerings within the company’s cardiac monitoring portfolio. It combines data readings comparable to clinical, site-based ECGs with Philips' cloud-based data collection and analysis services, enhancing convenience and accessibility for both patients and researchers.